The impact of COVID-19 national restrictions on dental antibiotic dispensing trends and treatment activity in England: January 2016 to July 2021.
Journal
JAC-antimicrobial resistance
ISSN: 2632-1823
Titre abrégé: JAC Antimicrob Resist
Pays: England
ID NLM: 101765283
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
07
06
2023
accepted:
26
06
2023
medline:
19
7
2023
pubmed:
19
7
2023
entrez:
19
7
2023
Statut:
epublish
Résumé
Reducing inappropriate antibiotic prescribing tempers the growing threat of antimicrobial resistance. We aimed to quantify the associated impact of COVID-19-related national restrictions in England on dental antibiotic dispensing and describe changes in appointments and modes of delivery of care. Interrupted time series analyses were completed using NHS Business Service Authority (NHSBSA) ePACT2 data to measure the associated change in antibiotic dispensing in England following COVID-19-related restrictions (which began March 2020). For face-to-face dental consultations, NHS dental treatment plan (FP17) data were used. For remote consultations during the COVID-19 period, NHSBSA Compass system remote management data were used. Between January 2016 and February 2020, there was a decreasing trend in antibiotic dispensing (-0.02 per 1000 population per month, Dental antibiotic prescribing significantly increased with the national COVID-19 restrictions when service delivery was altered with the closure of dental practices and introduction of remote consultations. Teledentistry was likely associated with inappropriate antibiotic prescribing. Continued antimicrobial stewardship and prudent use of antibiotics in dentistry is important.
Identifiants
pubmed: 37465106
doi: 10.1093/jacamr/dlad081
pii: dlad081
pmc: PMC10350668
doi:
Types de publication
Journal Article
Langues
eng
Pagination
dlad081Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy.
Références
Br Dent J. 2023 Jan 24;:
pubmed: 36693963
Fam Pract. 2022 May 28;39(3):420-425
pubmed: 34755180
Int J Epidemiol. 2013 Aug;42(4):1187-95
pubmed: 23760528
Br Dent J. 2020 Nov;229(9):601-604
pubmed: 33188343
Int J Environ Res Public Health. 2021 Aug 08;18(16):
pubmed: 34444131
J Med Internet Res. 2020 May 11;22(5):e18378
pubmed: 32391799
Br Dent J. 2021 Jan 21;:
pubmed: 33479515
BMC Med Res Methodol. 2021 Mar 22;21(1):58
pubmed: 33752604
Euro Surveill. 2021 Nov;26(46):
pubmed: 34794534
Lancet Infect Dis. 2021 Jun;21(6):e144
pubmed: 33275941
Clin Microbiol Infect. 2021 Feb 16;:
pubmed: 33601010
Am J Manag Care. 2021 Jan;27(1):21-26
pubmed: 33471458
Antibiotics (Basel). 2022 May 11;11(5):
pubmed: 35625287
Br Dent J. 2021 Jan 21;:
pubmed: 33479516
Prim Dent J. 2021 Sep;10(3):47-54
pubmed: 34727770
Br Dent J. 2022 Oct;233(8):653-658
pubmed: 36307710
Br Dent J. 2020 Jun;228(12):964-970
pubmed: 32591713
Br Dent J. 2020 Aug;229(3):196-200
pubmed: 32811949
Lancet Planet Health. 2021 Dec;5(12):e893-e904
pubmed: 34774223
Br Dent J. 2021 Nov 23;:
pubmed: 34815483
Antibiotics (Basel). 2021 Jul 10;10(7):
pubmed: 34356762
JDR Clin Trans Res. 2021 Apr;6(2):145-152
pubmed: 33423578